arrow
D

Daniel Mukadi-Bamuleka

institute nacional de recherche biomedical
H指数:21
被引数:3,986

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early insights into predicted efficacy of Ebola monoclonal antibodies for the 2026 Bundibugyo virus disease outbreak

2026年本迪布焦病毒病暴发中埃博拉单克隆抗体预测疗效的早期见解

2026-09-260
OA
Phylogenetic analysis of the 2025 Ebola outbreak in the Democratic Republic of the Congo

2025年刚果民主共和国埃博拉疫情的系统发育分析

2026-09-040
OA
Emergence of a Bundibugyo virus variant in the 2026 outbreak in the Democratic Republic of the Congo and Uganda

2026年刚果民主共和国和乌干达暴发中Bundibugyo病毒变种的 emergence

2026-08-100
OA
Performance of five mpox antigen-based rapid diagnostic tests tested on lesion swabs from patients with suspected mpox from the Kinshasa province of DR Congo: a diagnostic accuracy study

五种猴痘抗原快速诊断试剂在刚果民主共和国基桑加省疑似猴痘患者皮损棉签样本中的性能:一项诊断准确性研究

2026-08-011
PRE
When it could have been prevented: A maternal death from postpartum hemorrhage due to genital tract lesions complicated by urinary fistula in an Ebola treatment unit in DR Congo

本可预防的死亡:一名因生殖道损伤并发尿瘘导致产后出血死亡的孕产妇——来自刚果民主共和国埃博拉治疗中心的病例报告

2026-06-230
OAAI
Mpox seroprevalence in general population groups in South-Kivu, Democratic Republic of the Congo: a comparative description before and during the clade Ib outbreak

南基伍省一般人群中猴痘血清流行率:在分支Ib疫情前后及期间的比较描述

2026-04-270
OA
Multicountry genomic analysis underscores regional cholera spread in Africa

多国基因组分析强调了非洲地区霍乱的传播。

2026-02-090
OAAI
Investigating the spatiotemporal links between the EVD outbreaks in Likati (2017) and Eastern DRC (2018–2020): a retrospective transdisciplinary study

调查Likati (2017)和Eastern DRC (2018–2020)埃博拉病毒病(EVD)疫情之间的时空联系:一项回顾性跨学科研究

2026-02-030
OAAI
Epidemiological characteristics of monkeypox virus Clade Ib in the Democratic Republic of the Congo

刚果民主共和国猴痘病毒Ib谱系的流行病学特征

2025-12-060
OAAI
First imported cases of MPXV Clade Ib from Goma, Democratic Republic of the Congo

首次从刚果民主共和国戈马进口的MPXV Clade Ib病例

2025-11-150
OAAI
Corrigendum to “Long-term antibody responses to the Ebola virus and the vaccine vector after rVSV-ZEBOV vaccination in DRC” [Vaccine 62 (2025) 127537]

勘误:致“刚果民主共和国rVSV-ZEBOV疫苗接种后埃博拉病毒和疫苗载体的长期抗体反应”[Vaccine 62 (2025) 127537]

Vaccine
IF3.5
2025-09-170
PRE
Long-term Sequelae in Ebola Virus Disease Survivors Receiving Anti-Ebola Virus Therapies in the Democratic Republic of the Congo: A Prospective Cohort Study

在刚果民主共和国接受抗埃博拉病毒治疗的患者中,埃博拉病毒病幸存者的长期后遗症:一项前瞻性队列研究

2025-08-010
OAAI
Long-term antibody responses to the Ebola virus and the vaccine vector after rVSV-ZEBOV vaccination in DRC

刚果民主共和国接种rVSV-ZEBOV疫苗后对埃博拉病毒和疫苗载体的长期抗体应答

Vaccine
IF3.5
2025-07-230
PRE
Clustering and visualisation of the GABRIEL network expertise in the field of infectious diseases

GABRIEL网络在传染病领域的专业知识聚类与可视化

2025-05-160
OA
Clade Ia Monkeypox Virus Linked to Sexual Transmission, Democratic Republic of the Congo, August 2024

Ia进化支猴痘病毒与性传播相关,刚果民主共和国,2024年8月

2025-05-010
PRE
Maternal and fetal survival following Ebola, HIV and Malaria co-infection in the first trimester of gestation in resource-limited setting in Democratic Republic of Congo

刚果民主共和国资源受限环境下,孕早期埃博拉、艾滋病和疟疾合并感染后的母婴生存情况

2025-02-260
OA
Global genomic surveillance of monkeypox virus
2024-10-230
PRE
Dysglycaemia in Ebola virus disease: a retrospective analysis from the 2018 to 2020 outbreak
2024-08-010
PRE